의료용 특수 의자 시장 - 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문 예측(2024-2030년)

Specialty Medical Chairs Market Growth & Trends:

The global specialty medical chairs market size is expected to reach USD 7.0 billion by 2030, expanding at a CAGR of 7.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing geriatric population is one of the major factors boosting the specialty medical chairs market. As per the WHO, it is estimated that from 2025 to 2050, the older population is expected to almost double to 1.6 billion globally. According to The World Bank, the population in the Asia Pacific region is aging rapidly.

In East Asia and the Pacific, there were more than 211 million people aged 65 and over in 2010. The elderly population is expected to grow by 22% every five years in East Asia. This shows the potential demand for geriatric chairs in the coming years, which will subsequently propel the specialty medical chairs market. The rising prevalence of lifestyle-associated diseases, such as obesity, chronic kidney disease, diabetes, and cardiovascular diseases (CVDs), is also expected to augment the specialty medical chairs market. Furthermore, surging cases of paralysis and spinal injuries are expected to foster specialty medical chairs market growth during the forecast period.

Supportive regulatory frameworks and increasing reimbursement policies in developed economies are anticipated to drive market growth. For instance, Medicare policies in the U.S. offer reimbursement for equipment, such as wheelchairs, recliners, and others. Furthermore, the examination and treatment rates at dental, ophthalmic, and gynecology clinics decreased significantly, which can be attributed to the lockdown imposed in various countries due to the pandemic and the growing preference for online consultations. Various domestic and international companies faced major supply chain challenges due to the pandemic. However, major countries in Asia, such as China and South Korea, are on a steady path to recovery, thereby spurring market growth.

Specialty Medical Chairs Market Report Highlights:

• The rehabilitation product segment held the dominant share of over 40.1% in 2023, owing to the rise in the geriatric population
• In 2023, dialysis chairs held the largest share in the examination product segment owing to the increased prevalence of chronic kidney diseases and the rise in funding to centers for better equipment
• The treatment product segment is anticipated to register the fastest CAGR during the forecast period as these products are required for carrying out various treatment procedures, such as dental, and offer better comfort to patients during these procedures
• Asia Pacific is anticipated to be the fastest-growing regional market from 2024 to 2030 owing to improving healthcare infrastructure, growing geriatric population, and rising disposable income levels

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Market Definitions
    • 1.1.1.1. Product Segment
    • 1.1.1.2. End-use Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Objectives
• 1.5. Research Methodology
• 1.6. Information Procurement
  • 1.6.1. Purchased Database
  • 1.6.2. GVR's Internal Database
  • 1.6.3. Secondary Sources
  • 1.6.4. Primary Research
• 1.7. Information Analysis
  • 1.7.1. Data Analysis Models
• 1.8. Market Formulation & Validation
• 1.9. Model Details
  • 1.9.1. Commodity Flow Analysis
• 1.10. List of Secondary Sources
• 1.11. List of Abbreviations

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Growing geriatric population
    • 3.2.1.2. Increasing reimbursement policies
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of specialty medical chairs
• 3.3. Business Environment Analysis
  • 3.3.1. PESTLE Analysis
  • 3.3.2. Porter's Five Forces Analysis

Chapter 4. Specialty Medical Chairs Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

• 4.1. Specialty Medical Chairs market: Product Movement Analysis, 2023 & 2030
• 4.2. Examination chairs
  • 4.2.1. Examination Chairs Market, 2018 - 2030 (USD Million)
  • 4.2.2. Birthing chairs
    • 4.2.2.1. Birthing chairs market, 2018 - 2030 (USD Million)
  • 4.2.3. Cardiac chairs
    • 4.2.3.1. Cardiac chairs market, 2018 - 2030 (USD Million)
  • 4.2.4. Blood drawing chairs
    • 4.2.4.1. Blood drawing chairs market, 2018 - 2030 (USD Million)
  • 4.2.5. Dialysis chairs
    • 4.2.5.1. Birthing chairs market, 2018 - 2030 (USD Million)
  • 4.2.6. Mammography chairs
    • 4.2.6.1. Mammography chairs market, 2018 - 2030 (USD Million)
• 4.3. Treatment chairs
  • 4.3.1. Treatment Chairs Market, 2018 - 2030 (USD Million)
  • 4.3.2. Ophthalmic chairs
    • 4.3.2.1. Ophthalmic chairs market, 2018 - 2030 (USD Million)
  • 4.3.3. ENT chairs
    • 4.3.3.1. ENT chairs market, 2018 - 2030 (USD Million)
  • 4.3.4. Dental chairs
    • 4.3.4.1. Dental chairs market, 2018 - 2030 (USD Million)
  • 4.3.5. Others
    • 4.3.5.1. Others market, 2018 - 2030 (USD Million)
• 4.4. Rehabilitation chairs
  • 4.4.1. Rehabilitation Chairs Market, 2018 - 2030 (USD Million)
  • 4.4.2. Pediatric chairs
    • 4.4.2.1. Pediatric chairs market, 2018 - 2030 (USD Million)
  • 4.4.3. Bariatric chairs
    • 4.4.3.1. Bariatric chairs market, 2018 - 2030 (USD Million)
  • 4.4.4. Geriatric chairs
    • 4.4.4.1. Geriatric chairs market, 2018 - 2030 (USD Million)
  • 4.4.5. Others
    • 4.4.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Specialty Medical Chairs Market - Segment Analysis, by End-use, 2018 - 2030 (USD Million)

• 5.1. Specialty Medical Chairs Market: End-use Movement Analysis, 2023 & 2030
• 5.2. Hospitals
  • 5.2.1. Hospitals Market, 2018 - 2030 (USD Million)
• 5.3. Clinics
  • 5.3.1. Clinics Market, 2018 - 2030 (USD Million)
• 5.4. Others
  • 5.4.1. Others Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

• 6.1. Regional Market Snapshot
• 6.2. North America
  • 6.2.1. North America Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
  • 6.2.2. U.S.
    • 6.2.2.1. U.S. Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.2.2.2. Key Country Dynamics
    • 6.2.2.3. Regulatory Framework
    • 6.2.2.4. Competitive Scenario
  • 6.2.3. Canada
    • 6.2.3.1. Canada Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.2.3.2. Key Country Dynamics
    • 6.2.3.3. Regulatory Framework
    • 6.2.3.4. Competitive Scenario
• 6.3. Europe
  • 6.3.1. Europe Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
  • 6.3.2. Germany
    • 6.3.2.1. Germany Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.3.2.2. Key Country Dynamics
    • 6.3.2.3. Regulatory Framework
    • 6.3.2.4. Competitive Scenario
  • 6.3.3. UK
    • 6.3.3.1. UK Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.3.3.2. Key Country Dynamics
    • 6.3.3.3. Regulatory Framework
    • 6.3.3.4. Competitive Scenario
  • 6.3.4. France
    • 6.3.4.1. France Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.3.4.2. Key Country Dynamics
    • 6.3.4.3. Regulatory Framework
    • 6.3.4.4. Competitive Scenario
  • 6.3.5. Italy
    • 6.3.5.1. Italy Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.3.5.2. Key Country Dynamics
    • 6.3.5.3. Regulatory Framework
    • 6.3.5.4. Competitive Scenario
  • 6.3.6. Spain
    • 6.3.6.1. Spain Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.3.6.2. Key Country Dynamics
    • 6.3.6.3. Regulatory Framework
    • 6.3.6.4. Competitive Scenario
  • 6.3.7. Denmark
    • 6.3.7.1. Denmark Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.3.7.2. Key Country Dynamics
    • 6.3.7.3. Regulatory Framework
    • 6.3.7.4. Competitive Scenario
  • 6.3.8. Sweden
    • 6.3.8.1. Sweden Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.3.8.2. Key Country Dynamics
    • 6.3.8.3. Regulatory Framework
    • 6.3.8.4. Competitive Scenario
  • 6.3.9. Norway
    • 6.3.9.1. Norway Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.3.9.2. Key Country Dynamics
    • 6.3.9.3. Regulatory Framework
    • 6.3.9.4. Competitive Scenario
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
  • 6.4.2. Japan
    • 6.4.2.1. Japan Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.4.2.2. Key Country Dynamics
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. Competitive Scenario
  • 6.4.3. China
    • 6.4.3.1. China Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.4.3.2. Key Country Dynamics
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Competitive Scenario
  • 6.4.4. India
    • 6.4.4.1. India Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.4.4.2. Key Country Dynamics
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. Competitive Scenario
  • 6.4.5. South Korea
    • 6.4.5.1. South Korea Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.4.5.2. Key Country Dynamics
    • 6.4.5.3. Regulatory Framework
    • 6.4.5.4. Competitive Scenario
  • 6.4.6. Australia
    • 6.4.6.1. Australia Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.4.6.2. Key Country Dynamics
    • 6.4.6.3. Regulatory Framework
    • 6.4.6.4. Competitive Scenario
  • 6.4.7. Thailand
    • 6.4.7.1. Thailand Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.4.7.2. Key Country Dynamics
    • 6.4.7.3. Regulatory Framework
    • 6.4.7.4. Competitive Scenario
• 6.5. Latin America
  • 6.5.1. Latin America Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
  • 6.5.2. Key Country Dynamics
  • 6.5.3. Regulatory Framework
  • 6.5.4. Competitive Scenario
  • 6.5.5. Brazil
    • 6.5.5.1. Brazil Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.5.5.2. Key Country Dynamics
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. Competitive Scenario
  • 6.5.6. Mexico
    • 6.5.6.1. Mexico Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.5.6.2. Key Country Dynamics
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. Competitive Scenario
  • 6.5.7. Argentina
    • 6.5.7.1. Argentina Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.5.7.2. Key Country Dynamics
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Competitive Scenario
• 6.6. MEA
  • 6.6.1. MEA Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
  • 6.6.2. South Africa
    • 6.6.2.1. South Africa Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.6.2.2. Key Country Dynamics
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Competitive Scenario
  • 6.6.3. Saudi Arabia
    • 6.6.3.1. Saudi Arabia Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.6.3.2. Key Country Dynamics
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. Competitive Scenario
  • 6.6.4. UAE
    • 6.6.4.1. UAE Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.6.4.2. Key Country Dynamics
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. Competitive Scenario
  • 6.6.5. Kuwait
    • 6.6.5.1. Kuwait Specialty Medical Chairs Market, 2018 - 2030 (USD Million)
    • 6.6.5.2. Key Country Dynamics
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. Competitive Scenario

Chapter 7. Competitive Landscape

• 7.1. Company Categorization
• 7.2. Strategy Mapping
  • 7.2.1. Acquisition
  • 7.2.2. Collaborations
  • 7.2.3. New Platform Launches
  • 7.2.4. Others
• 7.3. Company Profiles/Listing
  • 7.3.1. A-dec, Inc.
    • 7.3.1.1. Company Overview
    • 7.3.1.2. Financial Performance
    • 7.3.1.3. Platform Benchmarking
    • 7.3.1.4. Strategic Initiatives
  • 7.3.2. ActiveAid, Inc
    • 7.3.2.1. Company Overview
    • 7.3.2.2. Financial Performance
    • 7.3.2.3. Platform Benchmarking
    • 7.3.2.4. Strategic Initiatives
  • 7.3.3. DentalEZ, Inc
    • 7.3.3.1. Company Overview
    • 7.3.3.2. Financial Performance
    • 7.3.3.3. Platform Benchmarking
    • 7.3.3.4. Strategic Initiatives
  • 7.3.4. Fresenius Medical Care AG & Co. KGaA
    • 7.3.4.1. Company Overview
    • 7.3.4.2. Financial Performance
    • 7.3.4.3. Platform Benchmarking
    • 7.3.4.4. Strategic Initiatives
  • 7.3.5. Topcon Corp.
    • 7.3.5.1. Company Overview
    • 7.3.5.2. Financial Performance
    • 7.3.5.3. Platform Benchmarking
    • 7.3.5.4. Strategic Initiatives
  • 7.3.6. Midmark Corp.
    • 7.3.6.1. Company Overview
    • 7.3.6.2. Financial Performance
    • 7.3.6.3. Platform Benchmarking
    • 7.3.6.4. Strategic Initiatives
  • 7.3.7. Danaher (KaVo Dental GmbH)
    • 7.3.7.1. Company Overview
    • 7.3.7.2. Financial Performance
    • 7.3.7.3. Platform Benchmarking
    • 7.3.7.4. Strategic Initiatives
  • 7.3.8. Dentsply Sirona
    • 7.3.8.1. Company Overview
    • 7.3.8.2. Financial Performance
    • 7.3.8.3. Platform Benchmarking
    • 7.3.8.4. Strategic Initiatives
  • 7.3.9. Planmeca Oy
    • 7.3.9.1. Company Overview
    • 7.3.9.2. Financial Performance
    • 7.3.9.3. Platform Benchmarking
    • 7.3.9.4. Strategic Initiatives
  • 7.3.10. Hill Laboratories Company
    • 7.3.10.1. Company Overview
    • 7.3.10.2. Financial Performance
    • 7.3.10.3. Platform Benchmarking
    • 7.3.10.4. Strategic Initiatives